跳至主要内容
临床试验/jRCTs041210128
jRCTs041210128招募中不适用

The effects of synbiotic 1-kestose and Bifidobacterium longum on the gut microbiota in patients with cancer therapy

未提供0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized Controlled Trial
干预模型
Single Assignment
主要目的
Other
盲法
Open(masking Not Used)

入排标准

年龄范围
20age old over 至 No limit(—)
性别
All

入选标准

  • •Patients who have received sufficient explanation before participating in this study, and have obtained written consent by their own free will with sufficient understanding.
  • •Patients aged 20 at the time of consent.
  • •Patients who have been receiving chemotherapy.

排除标准

  • •Patients who are judged to be inappropriate by the investigator and the investigator.

结局指标

主要结局

-

Evaluation of the intestinal microbiota and the Bristol stool scale

次要结局

  • ORR, DCR, PFS
  • Liver function (CP score and ALBI Grade)
  • Adverse events
  • Overall survival (OS)
  • Nutrition state improvement
  • Nutrition state evaluation (VAS)
  • Performance status

研究者

发起方
未提供

相似试验